Statistics
Publications
33
Citations
7K
H-Index
21
Active since
2006
Robin Mogg is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, medicine, and oncology.
Publications per year
2006–2025
33
33
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations
Medicine, Immunology, Oncology +17
Susan Buchbinder, Devan V. Mehrotra, Ann Duerr et al. · The Lancet · 2008 · 1.7K citations · Full text
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone, Chul Kim, Jillian Thompson et al. · The Lancet Oncology · 2018 · 400 citations · Full text
Medicine, Oncology, Pharmacology +10
1–5 of 33